Clinical application of magnetic resonance lymphangiography in the vascularized omental lymph nodes transfer with or without lymphaticovenous anastomosis for cancer-related lower extremity lymphedema
Introduction
Although radical gynecological oncological surgery is recommended to clear tumors and prevent their recurrence, extensive regional lymph node dissection, scar hyperplasia, radiotherapy, and other factors can cause extremity lymphedema. It has been reported that surgery-related extremity lymphedema incidence is as high as 25% (1,2), which could seriously affect human physical and mental health and quality of life. In recent years, intraperitoneal lymph node flap represented by omental lymph node flap transfer has been used to reconstruct the lower extremity lymphatic system. Even though its applicability has been popularized because of its rich blood supply and abundant lymphatic tissue, concealed incision, low complication rate, and predictable surgical outcome, its blinded surgical approach may cause injury to the healthy lymph nodes and vessels, especially in the inguinal region. With the advent of magnetic resonance lymphangiography (MRL), surgeons can now acquire more intuitionistic and precise information about the lower extremities’ lymphatic system which helps for a better surgical planning and execution.
MRL with subcutaneous injection of gadolinium has been proposed as a safe method for preoperative assessment of lymphatic channels due to its high spatial resolution. The three dimensional (3D) imaging provided by MRL enables the visualization of small lymphatic channels beyond the capabilities of traditional lymphoscintigraphy (3,4). Several studies have demonstrated that MRL is capable of identifying lymphatic vessels that are not visible with indocyanine green (ICG) lymphography, particularly those located deep beneath the skin (>2 cm deep), while also providing detailed information on lymphatic channel number, depth, trajectory, and regions of dermal backflow. MRL is a valuable technique for preoperative mapping of functional lymphatics and adjacent veins in limbs, assessing tissues in the affected limb, and improving patient selection for optimal surgical choice for lymphedema (5-7). This study aimed to formulate a precise and individualized treatment plan in conjunction with a better incision design by applying MRL for the reconstruction and repairment of lower extremity lymphedema with the aid of vascularized omental lymph node transfer (VOLT).
Methods
The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the ethics board of Xiangya Hospital, Central South University and informed consent was taken from all the patients. From November 2021 to September 2022, 14 patients with cancer-related lower extremity lymphedema underwent VOLT with or without lymphaticovenous anastomosis (LVA) using MRL for preoperative evaluation. An AIR Technology™ Anterior Array Coli was placed over the most edematous areas, while the other anterior array coli covered the rest of the extremities. All patients underwent MRL under a magnetic resonance scanner, as previously reported (8,9). The patients were initially plain-scanned in a prone position. A mixture of 1 mL of lidocaine with 10 mL of gadolinium contrast agent was then prepared. All patients received an intra-dermal injection of the mixture in their double-toe pads, which was swiftly massaged to facilitate the proximal diffusion of the contrast agent. The specific sequences are shown in Table 1. All the patients enrolled in this article were measured leg circumference and calculate circumference reduction rate during the follow-up period. All statistical analyses were performed using SPSS 26.0 software (SPSS, Chicago, IL, USA). Data were expressed as mean ± standard error of mean, and a P value <0.05 was considered statistically significant.
Table 1
Sequence name | Sequence details | ||
---|---|---|---|
1 | 2 | 3 | |
MRI sequence | 3D-T2WI | T2WI | 3D-T1WI |
Orientation | COR | AXI | COR |
Field-of-view (mm²) | 360×468 | 400×280 | 360×468 |
Slice thickness (mm) | 3 | 6 | 1.4 |
TR (ms) | 2400 | 5129 | 7.3 |
TE (ms) | 90 | 85 | 1.1/(2.2/233.6) |
Bandwidth | 62.5 | 83.3 | 200 |
Flip angle | – | 111 | 15 |
NEX | 2 | 1 | 1 |
Scan time (min: sec) | 2:25 | 2:49 | 1:35 |
MRL, magnetic resonance lymphangiography; MRI, magnetic resonance imaging; COR, coronal; AXI, axial; T2WI, T2 weighted image; T1WI, T1 weighted image; TE, echo delay time; TR, repetition time; NEX, number of excitations.
Surgical operation
The incision design was based on the result of preoperative MRL combined with intraoperative ICG fluorescence. The choice of surgical approach is not only determined by the patients’ stage and appearance, but we will also consider performing VOLT in patients with non-significant edema if their lymph nodes and lymphatic vessels suggest poor function compared to normal images (Figures 1,2). We determined the anastomosing lymphatic vessels and designed the transverse incision to avoid injuring the healthy lymphatic vessels and lymph nodes by drawing the surgical incision in the recipient area of the skin flap. Then methylene blue was subcutaneously injected at 5–6 cm distal to the end of the incision. After incision, the dissociated blue-stained lymphatic vessels and the diameter-matched veins were selected for end-to-end anastomosis. It is worth noting that as long as the MRL and ICG fluorescence results showed the presence of healthy lymphatic vessels, LVA would be performed on these vessels; however, if the patient did not have sufficient healthy lymphatic vessels to undergo LVA alone and present with impaired inguinal lymph node function, we would resort to performing VOLT (Figure 3A-3C). LVA was performed under the microscope (Zeiss Kinevo 900, Oberjoken, Germany) using 11-0 Ethilon sutures (Ethicon, LLC, USA) (Figure 3D). After LVA, microsurgeons prepared the recipient site for the omental lymph node flap. Typically, the ankle region above the medial malleolus was being selected, with an S-shaped incision drawn before proceeding with the surgery. Another S-shaped incision was made just below the groin, preserving the femoral or superficial epigastric artery and its accompanying vein. Meanwhile the greater omentum was explored using laparoscopy by the general surgeon. The pedicles of the left and right gastroepiploic arteries were cut off with an ultrasonic scalpel, and Hammlock clips were used to mark the vascular pedicle. The vascularized omentum was then delivered to the lower limb, and was divided into several omental lymph node flaps of appropriate sizes at the recipient site under the microscope (Zeiss Kinevo 900, Oberjoken, Germany). The smaller flap close to the vascular pedicle was designed as a flow-through perforator flap transplanted to the distal recipient site, while the larger one was transplanted into the proximal site (Figures 4-7). The number of flaps used depended on the status of the lymphoedema. For the limb without a healthy inguinal lymph node, two flaps instead of one flap would be transplanted on the calf part. The vascular anastomoses were performed using 10-0 Prolene sutures (Ethicon, LLC, USA). Surgical drain was inserted after adequate hemostasis, and the incision of the first stage operation was closed directly. Clinical photos were taken during the operations and after the surgery, all patients underwent re-examination using MRL (Figure 8).
Statistics
Statistical analysis was performed using SPSS software (ver.26.0; SPSS, Chicago, IL, USA). Use the ROUT test to reject outliers and all the results are expressed as means ± standard error of mean.
Results
A total of 14 female patients with 19 extremities underwent VOLT. The mean patients’ age was 53.64±10.27 years (range, 33–64 years), the mean BMI was 26.99±4.11 kg/m2 (range, 18.7–32.5 kg/m2), and the mean follow-up time was 8.86±1.41 months (range, 7–11 months). Nine patients were diagnosed with cervical cancer, 4 with endometrial cancer, and 2 with ovarian cancer. The average duration of lymphedema symptoms was 5.86±3.79 years (range, 0.25–1 years). Ten patients were classified as stage II and 4 with stage III according to International Society of Lymphology (ISL). Three flaps of one patient were lost due to multi-drug-resistant infection while all the other 32 flaps survived. All patients except one underwent LVA, and the mean number of anastomoses was 1.53±1.90 (range, 0–3). The recipient arteries selected include the posterior tibial artery, superficial epigastric artery, adductors muscles perforator artery, medial circumflex femoral artery, and medial sural artery according to site and vessel condition seen during the surgery. The mean total operating time was 10.10±1.94 hours (range, 6.2–12.3 hours). Two patients developed postoperative recipient area effusion, and during the follow-up period, two patients were affected with lymphangitis. During the follow-up period, the reduction of the limb circumference was measured in term of percentage compared to pre-operative findings. The patients with post-operative effusion were placed negative pressure suction device after the second surgical debridement. When the effusion was completely eliminated, the negative pressure drainage device was removed and the patient followed complex decongestive therapy for 3 weeks. The measurement was performed by the same operating surgeon with more than 3 years of clinical experience. Measurements were made in 5 locations which included the ankle, 10 cm above the ankle, 10 cm below the inferior pole of the patella, 10 cm above the superior pole of the patella, and 20 cm above the superior pole of the patella. According to the above order, the mean circumference reduction rates were 15.64%±40.08%, 11.79%±30.69%, 20.25%±24.94%, 7.73%±30.05%, −1.517%±16.75%, respectively. The patients’ information is shown in Tables 2-4.
Table 2
Patients | Age (years) | BMI (kg/m2) | Cancer diagnosis | Lymphedema lasting time (years) | Affected limb | ISL stage | Follow-up (months) | Complication |
---|---|---|---|---|---|---|---|---|
1 | 44 | 30.8 | Cervical cancer | 10 | Right | II | 11 | None |
2 | 64 | 28.4 | Endometrial cancer | Left: 1; right: 6 | Both | II | 10 | Recipient area effusion |
3 | 43 | 29.4 | Cervical cancer | 7 | Both | II | 10 | None |
4 | 43 | 23 | Ovarian cancer | 11 | Both | II | 10 | None |
5 | 64 | 23.8 | Cervical cancer | 7 | Left | III | 10 | None |
6 | 55 | 28.2 | Cervical cancer | 4 | Both | II | 9 | None |
7 | 63 | 18.7 | Ovarian cancer | 0.8 | Right | II | 9 | None |
8 | 64 | 32.5 | Endometrial cancer | 11 | Left | III | 8 | None |
9 | 56 | 31.3 | Endometrial cancer | 5 | Right | III | 7 | None |
10 | 62 | 30.8 | Cervical cancer | 5 | Both | III | 7 | Multi-drug-resistant infection |
11 | 56 | 22.9 | Cervical cancer | 4 | Right | II | 7 | Recipient area effusion |
12 | 33 | 26.5 | Cervical cancer | 12 | Right | II | 9 | None |
13 | 60 | 22.8 | Cervical cancer | 0.25 | Right | II | 10 | None |
14 | 44 | 28.8 | Cervical cancer | 8 | Left | II | 7 | None |
Mean ± SEM | 53.64±10.27 | 26.99±4.11 | N/A | 5.86±3.79 | N/A | N/A | 8.86±1.41 | N/A |
BMI, body mass index; ISL, International Society of Lymphology; SEM, standard error of mean; N/A, not applicable.
Table 3
Patients | Flap numbers |
Flaps survival |
LVA numbers | Recipient arteries | Episode numbers of lymphangitis | Total surgery time (hours) | |
---|---|---|---|---|---|---|---|
Pre-operative follow-up | Post-operative follow-up | ||||||
1 | 2 | 2 | 0 | PTA, AMPA | 3 | 0 | 7.5 |
2 | 3 | 3 | Left: 1; right: 1 | SEA, AMPA | 7 | 0 | 12.3 |
3 | 3 | 3 | Left: 2; right: 1 | PTA, AMPA | Countless | 1 | 13 |
4 | 4 | 4 | Left: 0; right: 1 | PTA, AMPA | Countless | 0 | 9.5 |
5 | 3 | 3 | 2 | MCFA, MSA, PTA | Countless | 0 | 8.5 |
6 | 3 | 3 | Left: 3; right: 1 | PTA, AMPA | 0 | 0 | 12.3 |
7 | 1 | 1 | 2 | PTA | 3 | 0 | 6.2 |
8 | 2 | 2 | 2 | PTA, AMPA | 8 | 0 | 8.6 |
9 | 2 | 2 | 2 | PTA, AMPA | 11 | 0 | 10 |
10 | 4 | 1 | Left: 2; right: 2 | PTA, SEA | 3 | 1 | 11 |
11 | 2 | 2 | 2 | PTA, AMPA | 0 | 0 | 10 |
12 | 2 | 2 | 2 | PTA, AMPA | 2 | 0 | 11.5 |
13 | 2 | 2 | 3 | PTA, AMPA | 3 | 0 | 11 |
14 | 2 | 2 | 0 | PTA, AMPA | 1 | 0 | 10 |
Mean ± SEM | 2.50±0.85 | 2.29±0.83 | 1.53±1.90 | N/A | N/A | 0.14±0.36 | 10.10±1.94 |
LVA, lymphaticovenous anastomosis; PTA, posterior tibial artery; AMPA, adductors muscles perforator artery; SEA, superficial epigastric artery; MCFA, medial circumflex femoral artery; MSA, medial sural artery; SEM, standard error of mean; N/A, not applicable.
Table 4
Patients | Circumference reduction rate | ||||
---|---|---|---|---|---|
Plane 1 | Plane 2 | Plane 3 | Plane 4 | Plane 5 | |
1 | 43.2% | −41.2% | 37.5% | −38.3% | 11.8% |
2 | −7.7%/0.0% | 2.8%/6.7% | 6.2%/11.2% | 4.2%/8.3% | 4.2%/0.0% |
3 | −6.2%/−9.1% | 8.7%/0.8% | 4.9%/−2.4% | −0.9%/−1.1% | 0.8%/0.1% |
4 | −1.4%/0.9% | −0.3%/−5.1% | 4.7%/4.5% | 0.9%/5.1% | 2.3%/2.5% |
5 | 3.3% | −20.0% | 28.6% | 31.3% | −4.0% |
6 | 3.8%/4.3% | 6.6%/14.7% | 1.1%/2.4% | −5.6%/−2.9% | −6.3%/−2.9% |
7 | 69.0% | 61.5% | 93.3% | −34.3% | −31.4% |
8 | 77.5% | 0.0% | 48.1% | 3.8% | 68.6% |
9 | 70.2% | 39.8% | 68.5% | 38.6% | −14.7% |
10 | −8.9%/−1.2% | −8.1%/−1.5% | −1.6%/4.0% | −8.6%/5.3% | −5.1%/0.3% |
11 | 100.0% | 93.3% | 79.2% | 100.0% | −33.3% |
12 | −27.78% | −191.30% | −94.44% | 25.00% | −169.44% |
13 | −55.56% | 41.51% | 19.15% | −16.98% | 5.00% |
14 | 42.86% | 12.07% | 28.21% | 32.97% | 44.00% |
Mean ± SEM | 15.64%±40.08% | 11.79%±30.69% | 20.25%±24.94% | 7.73%±30.05% | −1.517%±16.75% |
The negative percentage indicated that the follow-up value was larger than the first measured value at that plate. Plane 1: ankle; Plane 2: 10 cm above the ankle; Plane 3: 10 cm below the inferior pole of the patella; Plane 4: 10 cm above the superior pole of the patella; Plane 5: 20 cm above the superior pole of the patella. Use the ROUT test to reject outliers and analyze the results which are expressed as means ± SEM. SEM, standard error of mean.
Discussion
Nowadays, personalized and precision treatment is the major trend in clinical medicine. Technical advances in magnetic resonance imaging have made it possible to develop a non-invasive visualization method of the lymphatic system, which was not possible in the past (10). With the advent of MRL technology, microsurgeons could provide individualized treatment and surgical management according to the varying conditions of patients. In this study, we combined the MRL technique and super-microsurgery technological capability. MRL, a noninvasive indirect lymphography, allows for comprehensive examination as the contrast agent used has strong absorption, better histocompatibility, and ease of metabolism (11).
The traditional imaging examinations for lymphedema involve ICG fluorescence and lymphoscintigraphy. ICG fluorescence, limited by the excitation light source, its investigation depth is unable to reach the deep inguinal lymph node group so the surgeons can’t evaluate the function of lymph nodes directly. Although lymphoscintigraphy can reflect the lymph nodes function to a certain extent, the results will miss the condition and location of lymphatic vessels. MRL involves the subcutaneous injection of a contrast agent, which is taken up by macrophages and retained in the lymph nodes before being absorbed by lymphatic drainage to reveal the lymphatic system. It has become the “gold standard” of diagnosis and guidance for formulating clinical treatment schemes as it has less trauma, less pain, short consumption time, clear images, and other benefits. The assessment of lymphedema limb is evaluated in terms of both the severity of edema and the condition of lymphatic tissue. Contrasted with other lymphangiography methods, MRL can reflect the fluid change of preoperative and postoperative limbs more objectively and accurately. All these methods emphasize the importance of MRL in guiding surgery design. In addition, in our another study, data analysis was performed momentarily on 51 patients with lymphedema underwent MRL (including 11 patients enrolled in this study), MRI stage was performed for the severity of lymphedema patients (ISL stage 0, I, II, III), and imaging features such as cellular, dermal thickening, muscle abnormalities, and distal lymphangiectasia were evaluated. The correlation between imaging results and clinical stage, distal lymphangiectasia and surgical method were evaluated in 24 patients who underwent LVA. The results indicated that the clinical stage of lymphedema was positively correlated with the MRI stage, MRI features such as distal lymphatic vessel dilatation and muscle abnormality were positively correlated with the ISL stage of lymphedema. Therefore, based on these preliminary results, we believe that MRL can provide important diagnostic information for the treatment of patients with lower limb lymphedema.
Based on the preoperative MRL and intra-operative ICG fluorescence result, we decided to perform LVA alone for the patients with healthy lymphatic vessels and nodes, for LVA should be regarded as the primary treatment for lymphedema, while vascularized lymph nodes transfer and liposuction may be considered as additional procedures, thus establishing this as the standard approach for lymphedema (12). However in our study, none of the enrolled patients had sufficient healthy lymphatic vessels, all of objects combined function impairment of inguinal lymph nodes (13,14). As for those with loss or hypofunction of lymph nodes or with severe lymphatic system injury, basing on the combined assessment result of MRL, ISL stage, and degree of clinical subcutaneous adipose hyperplasia and tissue fibrosis, we chose VOLT to improve their local tissue microenvironment and to reconstruct the collateral circulation of the peripheral lymphatic system which in turn could improve the edema and reduce the frequency of local infections.
In addition, to improve the patient’s overall condition, we employed the precision mapping of MRL as this could guide surgeons to avoid damaging to the normal healthy lymphatic tissue. Moreover, since the proximal recipient site of the lower limb was chosen at the inguinal region, performing VOLT at this location might cause injury to inguinal lymph node function; therefore, MRL results can also help the surgeons to avoid causing iatrogenic injury. Superficial lymph nodes flap transfer such as submandibular lymph nodes have been frequently employed as donor sites because of their clear architecture, simple harvesting, and long-lasting effect. However, the donor sites may develop lymphedema and lymphatic fistula. Besides, peripheral nerves can be easily damaged during surgery, and the patient’s postoperative beauty may be affected by the relatively large incision and prominent postoperative scar. In contrast, laparoscopic techniques can be used to sample omental lymph nodes with a hidden incision, slight bleeding, and other advantages, such as obtaining enough lymphoid tissues in one donor site, avoiding postoperative lymphedema, reducing limb edema more quickly due to the excellent adsorption capacity. What’s more, benefiting from its anatomical structure, the greater omentum has more lymph nodes than superficial flap and can be applied to treat multiple limb lymphedema, for these reasons many studies have reported that omental lymph node transfer is superior to superficial lymph node transfer in limb detumescence through the long-term follow-up result (15-19).
However, due to individual patient differences and other factors, such as technical conditions, there are some limitations in its clinical application. For instance, in patients with severe edema and fibrosis, using a 1 mL syringe to perform subcutaneous injection may lead to challenges such as high subcutaneous pressure that makes injecting the contrast agent difficult and may result into an overflow of the contrast agent after its administration. Similarly, during the process of mixing the agent with the local anesthetic, the high pressure generated may bring pain and fear to patients during the administration procedure. Besides, MRL guidance cannot be directly utilized in the operation that needs another ICG fluorescence to determine the result, as its accuracy and sensitivity are not as good as when used singly with MRL. Moreover, its clarity in patients with severe edema is poor, which sometimes misguides the operation and clinical judgment of surgeons. For patients with metal implants placed in their previous operation, the image quality will be affected because of the influence of such materials, and the long duration of the MR examination process will lead to metal thermogenic reactions. All these factors mentioned above may cause the failure of radiography. Finally, during the follow-up period, taking MRL is difficult for the patients due to the high cost and insufficient technical know-how of local hospitals; however, comparing the MRL results, the figures of measuring tape or body composition measuring instrument directly reflect the changes of the limbs, which are easier to understand for patients with low literacy.
Regarding the operation process in this study, we performed a one-stage 1–4 segments VOLT for the treatment of lower extremities lymphedema and designed an S-shaped incision to achieve an esthetic and covert postoperative appearance. Because the acquisition of the omentum is obtained by laparoscopy, postoperative adhesion of abdominal contents may occur after abdominal closure, and the survival and growth of residual omentum are uncertain after cutting off the vessel pedicle. Therefore, patients have only one operation opportunity, and a one-stage operation can not only treat lower extremities lymphedema but also reduce the pain and economic burden of multiple operations.
Despite advantages of one-stage operation, for patients with multiple sites of lymphedema, the multi-segment VOLT can be difficult, due to the long duration of surgery, high physical and technical demand for the skilled operators, and the difficulties of postoperative care. In addition, patients with combined perineum edema, in which the proximal incision is close to the perineum and anus, are unavoidably facing with the possibility of getting infected from their excretions. In this study, one of the patients was affected by postoperative infection leading to the loss of three flaps; therefore, extra caution should be exercised when surgeons design the incision pattern.
At present, there is still no consensus regarding the surgical incision design. The mainstream view is that transplanting the lymph node flap to the distal site can achieve a better postoperative outcome than the proximal choice, i.e., the edema fluid would move to the distal limb due to gravity so that the transplanted lymph node can better exert its “pump” function which collects the edema fluid through the regenerated collateral lymphatic system to the venous system. This has been confirmed in long-term follow-up studies (20-22).
In our surgery design, the recipient site was designed to be below the inguinal region to decrease the edema of the upper section of the thigh and perineum. Regarding the surgical strategy used, we considered that great omentum has potent abilities to secrete VGEF-C and absorb fluid. Moreover, since the outcome of two-segment VOLT is more effective than one-segment VOLT (16,23), we hypothesize that if the acquired omental volume is adequate, priority should be given to multi-segmental transplantation.
Furthermore, the different surgical areas should be treated differently to solve the edema of the calf and foot per time. Based on the MRL and ICG fluorescence results, we chose the anterior ankle region to perform LVA, and the medial calf or malleolus was selected as the VOLT recipient region. However, the proximal recipient area (i.e., thigh) usually suffered from more severe edema and fibrosis, so we transplanted the great omentum to obtain a better absorption capacity and improve the local microenvironment (24). Due to the large operation area, massive post-operation effusion will occur after this surgical procedure; therefore, much attention should be paid to reduce this harmful effect on the outcome of the surgery, such as placing negative pressure drainage apparatus during the surgery.
Conclusions
Our study showed that combining preoperative MRL and VOLT may help provide individualized and precise treatment and minimize surgical trauma and injury to healthy lymphatic vessels and nodes. We have demonstrated that VOLT has good postoperative outcomes for the treatment of cancer-related lower extremities lymphedema and can be recommended for surgical treatment of patients with such conditions.
Acknowledgments
Funding: This study was supported by
Footnote
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://qims.amegroups.com/article/view/10.21037/qims-22-1443/coif). The authors have no conflicts of interest to declare.
Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the ethics board of Xiangya Hospital, Central South University and informed consent was taken from all the patients.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Forte AJ, Huayllani MT, Boczar D, Ciudad P, McLaughlin SA. Lipoaspiration for the Treatment of Lower Limb Lymphedema: A Comprehensive Systematic Review. Cureus 2019;11:e5913. [Crossref] [PubMed]
- Chung JH, Baek SO, Park HJ, Lee BI, Park SH, Yoon ES. Efficacy and patient satisfaction regarding lymphovenous bypass with sleeve-in anastomosis for extremity lymphedema. Arch Plast Surg 2019;46:46-56. [Crossref] [PubMed]
- Pieper CC, Feisst A, Schild HH. Contrast-enhanced Interstitial Transpedal MR Lymphangiography for Thoracic Chylous Effusions. Radiology 2020;295:458-66. [Crossref] [PubMed]
- Mills M, van Zanten M, Borri M, Mortimer PS, Gordon K, Ostergaard P, Howe FA. Systematic Review of Magnetic Resonance Lymphangiography From a Technical Perspective. J Magn Reson Imaging 2021;53:1766-90. [Crossref] [PubMed]
- Forte AJ, Boczar D, Huayllani MT, Avila FR, Guliyeva G, Lu X, Mash WR, Kung TA. Use of magnetic resonance imaging lymphangiography for preoperative planning in lymphedema surgery: A systematic review. Microsurgery 2021;41:384-90. [Crossref] [PubMed]
- Franconeri A, Ballati F, Panzuto F, Raciti MV, Smedile A, Maggi A, Asteggiano C, Esposito M, Stoppa D, Lungarotti L, Bortolotto C, Giardini D, De Silvestri A, Calliada F. A proposal for a semiquantitative scoring system for lymphedema using Non-contrast Magnetic Resonance Lymphography (NMRL): Reproducibility among readers and correlation with clinical grading. Magn Reson Imaging 2020;68:158-66. [Crossref] [PubMed]
- Zeltzer AA, Brussaard C, Koning M, De Baerdemaeker R, Hendrickx B, Hamdi M, de Mey J. MR lymphography in patients with upper limb lymphedema: The GPS for feasibility and surgical planning for lympho-venous bypass. J Surg Oncol 2018;118:407-15. [Crossref] [PubMed]
- Mitsumori LM, McDonald ES, Wilson GJ, Neligan PC, Minoshima S, Maki JH. MR lymphangiography: How i do it. J Magn Reson Imaging 2015;42:1465-77. [Crossref] [PubMed]
- Liu NF, Lu Q, Jiang ZH, Wang CG, Zhou JG. Anatomic and functional evaluation of the lymphatics and lymph nodes in diagnosis of lymphatic circulation disorders with contrast magnetic resonance lymphangiography. J Vasc Surg 2009;49:980-7. [Crossref] [PubMed]
- Zhang Y, Sun X, Shen W, Hao K, Hao Q, Li X, Wang R. Systematic lymphatic abnormality-related osseous lesions: a study based on CT lymphangiography. Quant Imaging Med Surg 2022;12:4549-58. [Crossref] [PubMed]
- Cellina M, Oliva G, Menozzi A, Soresina M, Martinenghi C, Gibelli D. Non-contrast Magnetic Resonance Lymphangiography: an emerging technique for the study of lymphedema. Clin Imaging 2019;53:126-33. [Crossref] [PubMed]
- Imai H, Yoshida S, Mese T, Roh S, Fujita A, Sasaki A, Nagamatsu S, Koshima I. Correlation between Lymphatic Surgery Outcome and Lymphatic Image-Staging or Clinical Severity in Patients with Lymphedema. J Clin Med 2022;11:4979. [Crossref] [PubMed]
- Onoda S, Satake T, Hamada E. Super-microsurgery technique for lymphaticovenular anastomosis. J Vasc Surg Venous Lymphat Disord 2023;11:177-81. [Crossref] [PubMed]
- Moon KC, Kim HK, Lee TY, You HJ, Kim DW. Vascularized lymph node transfer for surgical treatments of upper versus lower extremity lymphedema. J Vasc Surg Venous Lymphat Disord 2022;10:170-8. [Crossref] [PubMed]
- Mazzaferro D, Song P, Massand S, Mirmanesh M, Jaiswal R, Pu LLQ. The Omental Free Flap-A Review of Usage and Physiology. J Reconstr Microsurg 2018;34:151-69. [Crossref] [PubMed]
- Ciudad P, Mouchammed A, Manrique OJ, Chang WL, Huang TCT, Chen HC. Comparison of long-term clinical outcomes among different vascularized lymph node transfers: 6-year experience of a single center's approach to the treatment of lymphedema. J Surg Oncol 2018;117:1346-7. [Crossref] [PubMed]
- Ciudad P, Manrique OJ, Adabi K, Huang TC, Agko M, Trignano E, Chang WL, Chen TW, Salgado CJ, Chen HC. Combined double vascularized lymph node transfers and modified radical reduction with preservation of perforators for advanced stages of lymphedema. J Surg Oncol 2019;119:439-48. [Crossref] [PubMed]
- Shah S, Lowery E, Braun RK, Martin A, Huang N, Medina M, Sethupathi P, Seki Y, Takami M, Byrne K, Wigfield C, Love RB, Iwashima M. Cellular basis of tissue regeneration by omentum. PLoS One 2012;7:e38368. [Crossref] [PubMed]
- Ciudad P, Kiranantawat K, Sapountzis S, Yeo MS, Nicoli F, Maruccia M, Sirimahachaiyakul P, Chen HC. Right gastroepiploic lymph node flap. Microsurgery 2015;35:496-7. [Crossref] [PubMed]
- Cheng MH, Chen SC, Henry SL, Tan BK, Chia-Yu Lin M, Huang JJ. Vascularized groin lymph node flap transfer for postmastectomy upper limb lymphedema: flap anatomy, recipient sites, and outcomes. Plast Reconstr Surg 2013;131:1286-98. [Crossref] [PubMed]
- Cheng MH, Huang JJ, Wu CW, Yang CY, Lin CY, Henry SL, Kolios L. The mechanism of vascularized lymph node transfer for lymphedema: natural lymphaticovenous drainage. Plast Reconstr Surg 2014;133:192e-8e. [Crossref] [PubMed]
- Ito R, Zelken J, Yang CY, Lin CY, Cheng MH. Proposed pathway and mechanism of vascularized lymph node flaps. Gynecol Oncol 2016;141:182-8. [Crossref] [PubMed]
- Zhang QX, Magovern CJ, Mack CA, Budenbender KT, Ko W, Rosengart TK. Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. J Surg Res 1997;67:147-54. [Crossref] [PubMed]
- Nipper ME, Dixon JB. Engineering the Lymphatic System. Cardiovasc Eng Technol 2011;2:296-308. [Crossref] [PubMed]